Time and Virtual Reality in Schizophrenia and Bipolar Disorder

Exclusion Criteria

• •Substance Use Disorders (as defined by DSM-V)
• •Intake of benzodiazepines (in the period before inclusion, for a duration equivalent to 5 half-lives of the product), cannabis (in the 2 months before inclusion) or hallucinogenic substances (in the period before inclusion, for a duration equivalent to 5 half-lives of the product).
• •A neurological pathology or sequelae
• •Attention Deficit Hyperactivity Disorder (ADHD)
• •Borderline personality disorder
• •Disabling sensory impairment, including visual acuity (corrected, if applicable) \< 0.8 (due to the use of visual aids) (Freiburg Vision Test, Bach 1996)
• •Person deprived of liberty or under the safeguard of justice
• •Pregnant, parturient or breastfeeding women
• •Subject in a period of exclusion defined by another clinical study.
• •Healthy volunteers only:
• •History of major neurological or psychiatric illness with ongoing psychotropic medication (i.e., antidepressant, thyroid regulator, antipsychotic, benzodiazepine or hypnotic).
• •Patients only:
• •Only patients treated with neuroleptics, whether or not combined with an anti-parkinsonian corrector or anti-depressant, will be included. Patients taking benzodiazepines will be excluded